Diagnostic Values of Intraoperative (1-84) Parathyroid Hormone Levels are Superior to Intact Parathyroid Hormone for Successful Parathyroidectomy in Patients With Chronic Kidney Disease.
OBJECTIVE
Persistent secondary hyperparathyroidism (SHPT) may occur because of residual cervicothoracic parathyroids in parathyroidectomy (PTX) patients with chronic kidney disease. We prospectively compared the predictive values of intraoperative plasma (1-84) parathyroid hormone (PTH) and intact PTH (iPTH) levels to improve the safety and efficacy of PTX.


METHODS
We included 100 healthy controls, 162 stage 5 chronic kidney disease patients without SHPT, and 214 patients who underwent PTX because of SHPT. Plasma iPTH and (1-84) PTH levels were measured before incision (io-iPTH0 and io-[1-84]PTH0, respectively) and 10 minutes (io-iPTH10 and io-[1-84]PTH10, respectively) and 20 minutes (io-iPTH20 and io-[1-84]PTH20, respectively) after removing all parathyroids. The percentage reduction of iPTH and (1-84) PTH at 10 minutes (io-iPTH10% and io-[1-84]PTH10%, respectively) and 20 minutes (io-iPTH20%, and io-[1-84]PTH20%, respectively) was calculated. iPTH and (1-84) PTH were measured using second- and third-generation PTH assays, respectively.


RESULTS
Compared with the controls and non-PTX patients, the PTX group had more obvious mineral metabolism disorders. There were 187 successful PTXs, 19 patients with persistent SHPT, and 8 patients lost to follow-up. The receiver operating characteristic curves revealed that io-(1-84)PTH10% >86.6% and io-(1-84)PTH20% >87.5% suggested successful PTX. The sensitivity of io-iPTH20% and io-(1-84)PTH20% were higher than those at the timepoint of 10 minutes. Moreover, the specificity and sensitivity of the (1-84) PTH reduction percentage were superior to that of iPTH.


CONCLUSION
Intraoperative reduction percentages of plasma (1-84) PTH levels are superior to iPTH for accurately predicting successful PTX, especially at 20 minutes after all cervicothoracic parathyroids had been resected.
['Xu|Fangyan|F|', 'Huang|Yaoyu|Y|', 'Zeng|Ming|M|', 'Zhang|Lina|L|', 'Ren|Wenkai|W|', 'Qian|Hanyang|H|', 'Cui|Ying|Y|', 'Yang|Guang|G|', 'Zhou|Wenbin|W|', 'Wang|Shui|S|', 'Huang|Hui|H|', 'Chen|Huimin|H|', 'Xiao|Yujie|Y|', 'Gao|Xueyan|X|', 'Gao|Zhanhui|Z|', 'Wang|Jing|J|', 'Liu|Cuiping|C|', 'Zhang|Jing|J|', 'Zhao|Baiqiao|B|', 'Bian|Anning|A|', 'Li|Fan|F|', 'Wan|Huiting|H|', 'Xing|Changying|C|', 'Zha|Xiaoming|X|', 'Wang|Ningning|N|']
D006801:Humans D006962:Hyperparathyroidism, Secondary D007676:Kidney Failure, Chronic D010280:Parathyroid Glands D010281:Parathyroid Hormone D016105:Parathyroidectomy
(1-84) parathyroid hormone intact parathyroid hormone parathyroidectomy chronic kidney disease secondary hyperparathyroidism intraoperative monitoring